Compare NMRK & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NMRK | ITGR |
|---|---|---|
| Founded | 1929 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.7B |
| IPO Year | 2017 | 2000 |
| Metric | NMRK | ITGR |
|---|---|---|
| Price | $17.43 | $83.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 8 |
| Target Price | $19.60 | ★ $95.00 |
| AVG Volume (30 Days) | ★ 926.1K | 626.8K |
| Earning Date | 02-13-2026 | 02-19-2026 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | ★ 94.50 | N/A |
| EPS | 0.59 | ★ 2.42 |
| Revenue | ★ $3,160,782,000.00 | $1,831,074,000.00 |
| Revenue This Year | $21.82 | $9.58 |
| Revenue Next Year | $9.86 | N/A |
| P/E Ratio | ★ $29.28 | $34.77 |
| Revenue Growth | ★ 20.95 | 9.54 |
| 52 Week Low | $9.65 | $62.00 |
| 52 Week High | $19.84 | $146.36 |
| Indicator | NMRK | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 50.39 | 68.52 |
| Support Level | $16.83 | $80.17 |
| Resistance Level | $17.82 | $85.23 |
| Average True Range (ATR) | 0.45 | 2.00 |
| MACD | -0.02 | 0.61 |
| Stochastic Oscillator | 63.16 | 79.27 |
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.